(Reuters) -Johnson & Johnson said on Thursday it has agreed to retain all talc-related liabilities arising from litigation in the United States and Canada and will “indemnify” newly fo[...]
Read more
Health
AbbVie posts weak sales of newer drugs as Humira faces fresh competition, shares fall
By Patrick Wingrove and Leroy Leo (Reuters) -AbbVie Inc on Thursday missed quarterly revenue estimates for its newer treatments, fueling concerns over the drugmaker’s attempts to cushion the blo[...]
Read more
China Evergrande gains more than 77% backing of Class A debt holders for debt restructuring incentive
HONG KONG (Reuters) – Embattled property developer China Evergrande Group said on Thursday that holders of more than 77% of its Class A offshore debt by value submitted support for its restructu[...]
Read more
AstraZeneca beats estimates on strong emerging market sales as COVID wanes
By Natalie Grover and Maggie Fick LONDON (Reuters) -AstraZeneca on Thursday beat expectations for first-quarter profit and revenue, as buoyant sales of cancer treatment Imfinzi and strong demand for i[...]
Read more
Bristol Myers looks to new CEO as competition from generic drugs heats up
By Michael Erman (Reuters) -Bristol Myers Squibb said on Wednesday evening its CEO Giovanni Caforio would step down in November and will be replaced by current Chief Commercialization Officer Chris Bo[...]
Read more
Eli Lilly raises annual profit forecast on strength of diabetes drug
(Reuters) -Eli Lilly and Co on Thursday raised its annual revenue and profit forecasts after topping first-quarter sales estimates on demand for its closely watched diabetes drug Mounjaro, ahead of a[...]
Read more
Merck beats first-quarter expectations on Keytruda, Gardasil strength
(Reuters) -Drugmaker Merck & Co Inc on Thursday posted better-than-expected results for the first quarter on the strength of its blockbuster cancer immunotherapy Keytruda and human papillomavirus[...]
Read more
Chinese spirit maker ZJLD drops 18% in Hong Kong debut, dimming IPO outlook
By Scott Murdoch and Donny Kwok (Reuters) -Chinese spirit maker ZJLD Group’s shares ended down 18% on their first day of trading on Thursday, dampening hopes that a positive debut for the larges[...]
Read more
Second judge says US not liable in Moderna COVID-19 vaccine patent case
By Blake Brittain (Reuters) – Moderna Inc failed to persuade a Delaware federal judge on Wednesday to shift liability from the company to the U.S. government for alleged patent infringement by M[...]
Read more